12 studies found for:    benzamide
Show Display Options
Rank Status Study
1 Completed Benzamide Derivates as Treatment of Clozapine-induced Hypersalivation
Condition: Clozapine-induced Hypersalivation
Intervention: Drug: Amisulpride, Moclobemide
2 Completed Metoclopramide as Treatment of Clozapine-induced Hypersalivation
Condition: Clozapine-induced Hypersalivation
Interventions: Drug: Metoclopramide;   Drug: placebo
3 Completed An Open-label Study Investigating the Disposition and QT/QTc Interval Effects of 400 mg [14C]-Iniparib(3.7 MBq, 100 µCi)
Condition: Advanced Solid Tumors
Intervention: Drug: Iniparib
4 Completed Safety and Pharmacokinetics of SAR240550 (BSI-201) Twice Weekly in Patients With Advanced Solid Tumors
Condition: Advance Solid Tumors
Interventions: Drug: Iniparib (SAR240550 - BSI-201);   Drug: Gemcitabine;   Drug: Carboplatin
5 Completed
Has Results
Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-Induced Nausea and Vomiting (MK-0517-031)
Condition: Chemotherapy-Induced Nausea and Vomiting (CINV)
Interventions: Drug: Fosaprepitant dimeglumine;   Drug: Fosaprepitant Placebo;   Drug: Dexamethasone;   Drug: Ondansetron;   Drug: Dexamethasone Placebo;   Drug: Ondansetron Placebo;   Drug: Rescue Therapy
6 Completed
Has Results
A Korean Study of Efficacy and Safety of Aprepitant-based Triple Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in the First Cycle of Moderately Emetogenic Chemotherapy (Non-doxorubicin Hydrochloride [Adriamycin] and Cyclophosphamide Regimens) (MK-0869-225) (KMEC)
Conditions: Nausea;   Vomiting
Interventions: Drug: Aprepitant;   Drug: Aprepitant Placebo;   Drug: Ondansetron;   Drug: Dexamethasone;   Drug: Ondansetron Placebo;   Drug: Rescue Therapy (granisetron, dolasetron, tropisetron or ondansetron; metoclopramide or alizapride).
7 Completed Study of Aprepitant (MK-0869) for Chemotherapy-Induced Nausea and Vomiting (CINV) in Adolescent Participants (MK-0869-097)
Condition: Vomiting
Interventions: Drug: aprepitant;   Drug: ondansetron;   Drug: dexamethasone;   Drug: placebo to aprepitant;   Drug: placebo to dexamethasone;   Drug: rescue medication
8 Recruiting Mocetinostat (MGCD0103) Plus Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Hodgkin Lymphoma
Condition: Hodgkin Lymphoma
Intervention: Drug: Mocetinostat Plus Brentuximab Vedotin
9 Recruiting SARC018: A Study of Mocetinostat and Gemcitabine in Patients With Metastatic Leiomyosarcoma
Condition: Metastatic Leiomyosarcoma
Interventions: Drug: Mocetinostat;   Drug: Gemcitabine
10 Recruiting Study of Mocetinostat in Selected Patients With Mutations of Acetyltransferase Genes in Relapsed and Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma
Conditions: Lymphoma;   Relapsed and Refractory;   Diffuse Large B-Cell Lymphoma and Follicular Lymphoma
Intervention: Drug: Mocetinostat
11 Active, not recruiting Study of Mocetinostat in Patients With Urothelial Carcinoma Having Inactivating Alterations of Specific Genes
Condition: Urothelial Carcinoma
Intervention: Drug: Mocetinostat
12 Completed Safety Study of Mocetinostat in Combination With Azacitidine in Subjects With MDS
Condition: Myelodysplastic Syndrome
Interventions: Drug: Mocetinostat;   Drug: Azacitidine

Indicates status has not been verified in more than two years